These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35189856)

  • 1. Drivers of purchase decisions for cannabis products among consumers in a legalized market: a qualitative study.
    Donnan J; Shogan O; Bishop L; Najafizada M
    BMC Public Health; 2022 Feb; 22(1):368. PubMed ID: 35189856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drivers of Purchase Decisions Among Consumers of Dried Flower Cannabis Products: A Discrete Choice Experiment.
    Donnan JR; Johnston K; Najafizada M; Bishop LD
    J Stud Alcohol Drugs; 2023 Sep; 84(5):744-753. PubMed ID: 37219026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics that influence purchase choice for cannabis products: a systematic review.
    Donnan J; Shogan O; Bishop L; Swab M; Najafizada M
    J Cannabis Res; 2022 Feb; 4(1):9. PubMed ID: 35105374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis edibles packaging: Communicative objects in a growing market.
    Ventresca M; Elliott C
    Int J Drug Policy; 2022 May; 103():103645. PubMed ID: 35276401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining attributes of retailers that influence where cannabis is purchased: a discrete choice experiment.
    Donnan JR; Downey M; Johnston K; Najafizada M; Bishop LD
    J Cannabis Res; 2024 Feb; 6(1):4. PubMed ID: 38331901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis flower prices and transitions to legal sources after legalization in Canada, 2019-2020.
    Wadsworth E; Driezen P; Pacula RL; Hammond D
    Drug Alcohol Depend; 2022 Feb; 231():109262. PubMed ID: 34998249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noticing of cannabis health warning labels in Canada and the US.
    Goodman S; Hammond D
    Health Promot Chronic Dis Prev Can; 2021; 41(7-8):201-210. PubMed ID: 34427418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of plain packaging and health warning labels for cannabis among young adults: findings from an experimental study.
    Mutti-Packer S; Collyer B; Hodgins DC
    BMC Public Health; 2018 Dec; 18(1):1361. PubMed ID: 30526539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring consumer preferences for cannabis edible products to support public health policy: A discrete choice experiment.
    Donnan J; Johnston K; Coombs M; Najafizada M; Bishop L
    PLoS One; 2024; 19(5):e0292336. PubMed ID: 38753807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of plain packaging and health warnings on consumer appeal of cannabis products.
    Goodman S; Leos-Toro C; Hammond D
    Drug Alcohol Depend; 2019 Dec; 205():107633. PubMed ID: 31678837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retail availability and legal purchases of dried flower in Canada post-legalization.
    Wadsworth E; Driezen P; Hammond D
    Drug Alcohol Depend; 2021 Aug; 225():108794. PubMed ID: 34098382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consumer perceptions of legal cannabis products in Canada, 2019-2021: a repeat cross-sectional study.
    Wadsworth E; Fataar F; Goodman S; Smith DM; Renard J; Gabrys R; Jesseman R; Hammond D
    BMC Public Health; 2022 Nov; 22(1):2048. PubMed ID: 36348479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceived Importance of Factors in Cannabis Purchase Decisions: A Best-worst Scaling Experiment.
    Zhu B; Guo H; Cao Y; An R; Shi Y
    Int J Drug Policy; 2021 May; 91():102793. PubMed ID: 32482489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Driving under the influence of cannabis: perceptions from Canadian youth.
    Donnan JR; Drakes DH; Rowe EC; Najafizada M; Bishop LD
    BMC Public Health; 2022 Dec; 22(1):2384. PubMed ID: 36536347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Content analysis of online product descriptions from cannabis retailers in six US states.
    Luc MH; Tsang SW; Thrul J; Kennedy RD; Moran MB
    Int J Drug Policy; 2020 Jan; 75():102593. PubMed ID: 31794923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of package colour, branding and health warnings on appeal and perceived harm of cannabis products among respondents in Canada and the US.
    Goodman S; Rynard VL; Iraniparast M; Hammond D
    Prev Med; 2021 Dec; 153():106788. PubMed ID: 34506816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Communicating THC levels and 'dose' to consumers: Implications for product labelling and packaging of cannabis products in regulated markets.
    Hammond D
    Int J Drug Policy; 2021 May; 91():102509. PubMed ID: 31351756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impacts of packaging on preferences for cannabis edibles: A discrete choice experiment.
    Cooper M; Shi Y
    Int J Drug Policy; 2024 Jun; 128():104453. PubMed ID: 38796927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019-2021: a repeat cross-sectional study.
    Wadsworth E; Rynard V; Driezen P; Freeman TP; Rychert M; Wilkins C; Hall W; Gabrys R; Hammond D
    Harm Reduct J; 2023 Feb; 20(1):19. PubMed ID: 36803833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the use of cannabis products in Canada and the USA, 2018 - 2020: Findings from the International Cannabis Policy Study.
    Hammond D; Goodman S; Wadsworth E; Freeman TP; Kilmer B; Schauer G; Pacula RL; Hall W
    Int J Drug Policy; 2022 Jul; 105():103716. PubMed ID: 35613480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.